Appointments: Celgene, Merck KGaA, Ipsen, Ablynx, Advicenne, Dragonfly, Ritter And The ABPI
Executive Summary
Company personnel changes in the past week include the CEO of Celgene adding to his responsibilities with the role of chairman, a new CIO at Merck KGaA, new CMOs at Ipsen and Dragonfly Therapeutics, and new CSOs at Ablynx and the ABPI. Vice presidents of clinical development have been named at Advicenne and Ritter Pharmaceuticals.
You may also be interested in...
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
With US House of Representatives now controlled by Democrats, lower chamber of Congress will likely increase hearings and investigations into industry pricing practices, but any legislation will likely need to dovetail with President Trump’s agenda to advance.
Democrat-Controlled House Will Turn Up The Volume On Drug Pricing
With US House of Representatives now controlled by Democrats, lower chamber of Congress will likely increase hearings and investigations into industry pricing practices, but any legislation will probably need to dovetail with President Trump’s agenda to advance.
Pipeline Watch: Phase III Readouts in Wilson Disease, Parkinson's Disease And COVID-19
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.